Drug
Imc S118ai
Imc S118ai: highest development phase Phase 1, developed by Immunocore. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Immunocore
Trials
| Drug | Phase | Indication |
|---|---|---|
| IMC-S118AI NCT07493122 | Phase 1 | Type 1 Diabetes |
Latest
No recent events.
Follow Imc S118ai on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.